A new study suggests that metformin, a common diabetes drug, could reduce the cardiovascular and metabolic benefits of exercise in patients with Type 2 diabetes. Research from Rutgers University found that participants taking metformin during exercise showed diminished improvements in blood sugar control, vascular function, and aerobic fitness compared to those who exercised without the medication.